Is ULIHF or NOBL a better dividend investment in 2026?

ULIHF currently yields 4.61% with a 5% 5-year dividend growth rate. NOBL yields 2.17% with 5% growth. The better choice depends on your goal: ULIHF offers higher current income.

What is the dividend yield difference between ULIHF and NOBL?

ULIHF has a forward dividend yield of 4.61% ($0.06/share annually). NOBL yields 2.17% ($2.27/share annually). The yield gap is 2.44 percentage points.

Home › Compare › ULIHF vs NOBL

ULIHF vs NOBL: Dividend Comparison 2026

ULIHF yields 4.61% · NOBL yields 2.17%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ULIHF wins by $3914.36M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ULIHF

● Live price

4.61%

Share price

$1.30

Annual div

$0.06

5Y div CAGR

100%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$3914.38M

Annual income

$3,757,849,931.79

Full ULIHF calculator →

NOBL

● Live price

2.17%

Share price

$104.67

Annual div

$2.27

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$22.9K

Annual income

$249.78

Full NOBL calculator →

Portfolio growth — ULIHF vs NOBL

📍 ULIHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ULIHF	NOBL
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ULIHF + NOBL cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ULIHF pays

NOBL pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ULIHF

Annual income on $10K today (after 15% tax)

$392.01/yr

After 10yr DRIP, annual income (after tax)

$3,194,172,442.02/yr

NOBL

Annual income on $10K today (after 15% tax)

$184.52/yr

After 10yr DRIP, annual income (after tax)

$212.31/yr

At 15% tax rate, ULIHF beats the other by $3,194,172,229.71/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ULIHF + NOBL for your $10,000?

ULIHF: 50%NOBL: 50%

100% NOBL50/50100% ULIHF

Portfolio after 10yr

$1957.20M

Annual income

$1,878,925,090.79/yr

Blended yield

96.00%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ULIHF buys

NOBL buys

No recent congressional trades found for ULIHF or NOBL in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricULIHFNOBL

Forward yield	4.61% ✓	2.17%
Annual dividend / share	$0.06	$2.27 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	100% ✓	0%
Portfolio after 10y	$3914.38M ✓	$22.9K
Annual income after 10y	$3,757,849,931.79 ✓	$249.78
Total dividends collected	$3903.33M ✓	$2.3K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: ULIHF vs NOBL ($10,000, DRIP)

Year	ULIHF Portfolio	ULIHF Income/yr	NOBL Portfolio	NOBL Income/yr	Gap
1← crossover	$11,622	$922.37	$10,917	$217.08	+$705.00 → ULIHF
2	$14,440	$2,003.76	$11,903	$221.48	+$2.5K → ULIHF
3	$20,104	$4,653.23	$12,962	$225.68	+$7.1K → ULIHF
4	$33,620	$12,109.28	$14,099	$229.68	+$19.5K → ULIHF
5	$73,826	$37,852.07	$15,319	$233.49	+$58.5K → ULIHF
6	$234,355	$155,361.26	$16,628	$237.10	+$217.7K → ULIHF
7	$1,172,599	$921,838.97	$18,033	$240.53	+$1.15M → ULIHF
8	$9,876,061	$8,621,381.00	$19,539	$243.78	+$9.86M → ULIHF
9	$146,291,644	$135,724,258.55	$21,154	$246.86	+$146.27M → ULIHF
10	$3,914,381,991	$3,757,849,931.79	$22,884	$249.78	+$3914.36M → ULIHF

ULIHF vs NOBL: Complete Analysis 2026

ULIHF — Stock

The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, nervous system drugs, vitamins, and vacant gelatin capsules, as well as API and intermediate products. It also manufactures and sells soft capsules casings; holds trademarks; and trades in pharmaceutical products. In addition, the company provides management services. It has operations in the People's Republic of China, Europe, India, the Middle East, South America, other Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong.

Full ULIHF Calculator →

NOBL — ETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →

📬

Get this ULIHF vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ULIHF vs SCHD ULIHF vs JEPI ULIHF vs O ULIHF vs KO ULIHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.